Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Independent Medicines and Medical Devices Safety Review report First Do No Harm, published on 8 July 2020, what steps they will take to provide monetary compensation for people adversely affected by clinical and surgical pelvic mesh.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the report from the Patient Safety Commissioner entitled The Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February 2024, whether she is taking steps to implement the recommendation that women treated with mesh should be compensated.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to The Hughes Report, published by the Patient Safety Commissioner on 7 February 2024, if she will ensure that people impacted by bowel mesh are eligible for financial redress.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course. Bowel mesh, also known as rectopexy mesh, did not fall within the definition of pelvic organ prolapse that the PSC investigated for her report.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when her Department plans to make a decision on financial redress for those harmed by pelvic mesh or sodium valproate.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the Commissioner and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the Commissioner’s recommendations and will respond substantively in due course.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published by the Patient Safety Commissioner on 7 February 2024, whether she has made an assessment of the potential implication for her policies of the provision of financial redress for people harmed by valproate and pelvic mesh.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what her planned timetable is for making a decision on redress for people affected by mesh implants following the publication of The Hughes Report on 7 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what her Department's planned timescale is for responding to the Patient Safety Commissioner's report entitled The Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, for what reason the compensation scheme for people suffering from the effects of vaginal mesh operations does not cover all those impacted by the use of the same materials in rectopexy procedures.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh.

While the PSC does not include rectopexy mesh within her proposed definition of directly harmed patients for the purposes of her redress recommendations, we note that the PSC has said in her report that the Government needs to consider how to investigate issues related to harm caused by other uses of mesh going forward. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to his correspondence of 28 February 2024 to Kath Sansom and Ruth MacLeod of the Sling the Mesh Group, if he will publish (a) the patient groups that contributed to, (b) the distribution lists used to inform (i) patient groups and (ii) stakeholders about and (c) a summary of the contributions of patient groups to the consultation.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Government is in the process of drafting the response to the consultation on Disclosure of industry payments to the healthcare sector, which will be published in due course. As the consultation response is in policy development, the information requested is not available.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what her planned timetable is to respond to the Patient Safety Commissioner's report entitled Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what her planned timetable is to respond to the Patient Safety Commissioner's report entitled Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when she plans to respond to the report by the Patient Safety Commissioner entitled The Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course.

Found: • Some reports do not include the necessary information to determine the indication of use of the surgical